Thrombostatin FM compounds: direct thrombin inhibitors - mechanism of action in vitro and in vivo.
Nieman, M.T., Burke, F., Warnock, M., Zhou, Y., Sweigart, J., Chen, A., Ricketts, D., Lucchesi, B.R., Chen, Z., Di Cera, E., Hilfinger, J., Kim, J.S., Mosberg, H.I., Schmaier, A.H.(2008) J Thromb Haemost 6: 837-845
- PubMed: 18315550 
- DOI: https://doi.org/10.1111/j.1538-7836.2008.02937.x
- Primary Citation of Related Structures:  
3BV9 - PubMed Abstract: 
Novel pentapeptides called Thrombostatin FM compounds consisting mostly of D-isomers and unusual amino acids were prepared based upon the stable angiotensin converting enzyme breakdown product of bradykinin - RPPGF.
Organizational Affiliation: 
Division of Hematology and Oncology, Department of Medicine, Case Western Reserve University, Cleveland, OH 44106-7284, USA.